ASSIST Act of 2025

The ASSIST Act of 2025, having been favorably reported with an amendment in the nature of a substitute by the Committee on Veterans' Affairs, is now positioned for further legislative action. This bill expands services and support for veterans, specifically focusing on healthcare access, mental health services, and potentially technology-driven solutions for care delivery. This development signals a clear intent to increase federal spending directed towards veteran welfare, creating immediate market opportunities for companies operating in these sectors. The funding mechanism for the ASSIST Act will likely involve increased appropriations to the Department of Veterans Affairs (VA), which then allocates funds through contracts, grants, and direct payments for services. Companies positioned to capture this funding include large healthcare providers like HCA Healthcare ($HCA) and Molina Healthcare ($MOH) through expanded service agreements. Diagnostic companies such as LabCorp ($LH) and Quest Diagnostics ($DGX) will see increased demand for testing services. Technology firms offering telehealth solutions, electronic health records (EHR) systems, and specialized veteran support platforms will also benefit. Pharmacy chains like CVS Health ($CVS) and Walgreens Boots Alliance ($WBA) will experience higher prescription volumes and related service utilization. Staffing agencies like AMN Healthcare Services ($AMN) will see increased demand for medical personnel. Historically, legislation expanding veteran benefits has consistently driven revenue for healthcare and related service providers. For instance, following the passage of the VA MISSION Act of 2018, which expanded veterans' access to community care, companies like TriWest Healthcare Alliance (a private company, but its partners saw increased activity) and other community providers experienced significant growth in patient volumes and contract awards. While specific market movements are difficult to isolate due to broader market conditions, the underlying demand for services increased substantially. The market reacted positively to the increased funding certainty for these sectors. Specific winners include LabCorp ($LH) and Quest Diagnostics ($DGX) due to increased diagnostic testing, CVS Health ($CVS) and Walgreens Boots Alliance ($WBA) from higher prescription fulfillment, and AMN Healthcare Services ($AMN) for staffing medical professionals. Large hospital systems like HCA Healthcare ($HCA) and managed care organizations like Molina Healthcare ($MOH) and Centene ($CNC) will benefit from expanded service contracts and increased patient enrollment. Technology companies specializing in veteran-specific digital health solutions, though often privately held, will also see increased acquisition or partnership opportunities. There are no clear losers, as the bill expands services rather than restricting them. The next step for S1726 is consideration by the full Senate, likely followed by House consideration if it passes the Senate. The favorable committee report indicates strong legislative momentum. If enacted, implementation would begin in late 2026 or early 2027, with contract awards and increased spending following shortly thereafter.